Through analyzing multiple levels of data from The Cancer Genome Atlas (TCGA), we comprehensively identified the molecular features, its association with tumor-infiltrating immune cells (TIILs), and the clinical relevance of the cGAS-STING pathway across a wide variety of cancer types. This evidence concerns the gene STING1 and neoplasm.